Glaukos Corporation , an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today. | May 1, 2023
Alcon innovations featured in approximately 180 abstracts across cataract, glaucoma, refractive, visualization and ocular health1
New data demonstrates comparable range of vision and intermediate. | May 1, 2023
Alcon innovations featured in approximately 180 abstracts across cataract, glaucoma, refractive, visualization and ocular health1 New data demonstrates comparable range of vision and intermediate
ALISO VIEJO, Calif. (BUSINESS WIRE) Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that its technologies will be featured in various scientific programmin.
Alcon innovations featured in approximately 180 abstracts across cataract, glaucoma, refractive, visualization and ocular health1New data demonstrates comparable range of vision and intermediate visual acuity between Clareon monofocal IOL and TECNIS Eyhance monofocal IOL2Alcon advances next-generation workflow conn.